University of the Sunshine Coast,Southbank
Welcome,         Profile    Billing    Logout  
 0 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sahai, Nischal
TRAILRUNNER-ALZ 3, NCT06653153: A Study of Remternetug (LY3372993) in Early Alzheimer's Disease

Recruiting
3
1200
Europe, Canada, Japan, US, RoW
Remternetug, LY3372993, Placebo
Eli Lilly and Company
Alzheimer's Disease
04/29
10/30
HD-MAP, NCT06417853: Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch

Recruiting
1
258
RoW
Unadjuvanted Influenza A (H7N9) Monovalent Vaccine Injection, Unadjuvanted Influenza A (H7N9) Monovalent Vaccine Microarray Patch Delivery System (low dose HA), Adjuvanted Influenza A (H7N9) Monovalent Vaccine Microarray Patch Delivery System (high dose HA), Adjuvanted Influenza A (H7N9) Monovalent Vaccine Injection, Adjuvanted Influenza A (H7N9) Monovalent Vaccine Microarray Patch Delivery System (low dose HA, low dose adjuvant), Adjuvanted Influenza A (H7N9) Monovalent Vaccine Microarray Patch Delivery System (low dose HA, high dose adjuvant), Adjuvanted Influenza A (H7N9) Monovalent Vaccine Microarray Patch Delivery System (high dose HA, low dose adjuvant), Adjuvanted Influenza A (H7N9) Monovalent Vaccine Microarray Patch Delivery System (high dose HA, high dose adjuvant), Microarray Patch Delivery System
Vaxxas Pty Ltd, Biomedical Advanced Research and Development Authority
H7N9 Influenza
05/26
05/26
NCT06556147: A Study of RSV-HMPV Bivalent Vaccine VXB-241 in Older Adults

Active, not recruiting
1
144
RoW
VXB-241 60 mcg (Low Dose), VXB-241 120 mcg (Medium Dose), VXB-241 240 mcg (Medium-high Dose), VXB-241 480 mcg (High Dose), VXB-241, Placebo, Arexvy 120 mcg
Vicebio Australia Proprietary Limited
Healthy Volunteers
08/25
05/27
Tait, Alexander
No trials found

Download Options